前收市價 | 4,438.00 |
開市 | 4,458.00 |
買盤 | 4,520.00 x 無 |
賣出價 | 4,521.00 x 無 |
今日波幅 | 4,458.00 - 4,543.00 |
52 週波幅 | 4,190.00 - 6,570.00 |
成交量 | |
平均成交量 | 2,702,044 |
市值 | 31.966B |
Beta 值 (5 年,每月) | 0.07 |
市盈率 (最近 12 個月) | 19.88 |
每股盈利 (最近 12 個月) | 2.27 |
業績公佈日 | 2024年2月28日 |
遠期股息及收益率 | 1.93 (4.34%) |
除息日 | 2024年4月11日 |
1 年預測目標價 | 5,663.13 |
Reckitt said on Monday that many cases had been filed against baby formula makers in general, and it was unclear how many directly related to its unit's Enfamil product. An Illinois jury last week ordered Reckitt unit Mead Johnson to pay $60 million to the mother of a premature baby who died of an intestinal disease after being fed the company's Enfamil baby formula. The jury in a state court in St. Clair County found Mead Johnson was negligent and had failed to warn of the risk of necrotising enterocolitis (NEC).
LONDON (Reuters) -Reckitt said on Monday that many cases had been filed against baby formula makers in general, and it was unclear how many directly related to its unit's Enfamil product. An Illinois jury last week ordered Reckitt unit Mead Johnson to pay $60 million to the mother of a premature baby who died of an intestinal disease after being fed the company's Enfamil baby formula. The jury in a state court in St. Clair County found Mead Johnson was negligent and had failed to warn of the risk of necrotising enterocolitis (NEC).
London-listed shares of the consumer goods giant dropped more than 15% to their lowest in a decade, as the verdict triggered fears that Reckitt would face more financial liabilities from lawsuits related to the baby formula. An Illinois jury ordered Reckitt unit Mead Johnson on Wednesday to pay $60 million to the mother of a premature baby who died of an intestinal disease after being fed Enfamil. "We strongly disagree with the jury's decision to fault Mead Johnson and award damages," Reckitt said in a statement on Friday.